Search research articles
Contact Us
Filters
Showing results (81-90 of 283) with videos related to
Page
of 29
Sort By:
Nature Reviews. Urology
|
October 12, 2016
Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations
Jeffrey J Tosoian, Michael A Gorin, Ashley E Ross, et al.
Nature Reviews. Urology
|
March 2, 2021
Local anaesthetic techniques for performing transperineal prostate biopsy
Spyridon P Basourakos, Mathew J Allaway, Ashley E Ross, et al.
Journal of Surgical Oncology
|
October 29, 2024
Treatment Modalities and Risks of Complication for Patients With Localized Renal Cell Carcinoma Aged 75 and Older
Chalairat Suk-Ouichai, Hiten D Patel, Kent T Sato, et al.
ACS Sensors
|
February 21, 2024
Waste Coffee Ground-Derived Porous Carbon for Neurochemical Detection
Blaise J Ostertag, Ayah J Syeed, Alexandra K Brooke, et al.
The Oncologist
|
May 11, 2026
The emerging role of prostate-specific membrane antigen-targeted radioligand therapy in metastatic hormone-sensitive prostate cancer
Philipose Mulugeta, Tanya Dorff, Jason Hafron, et al.
The Journal of Urology
|
October 28, 2017
Tumor Volume on Biopsy of Low Risk Prostate Cancer Managed with Active Surveillance
Jeffrey J Tosoian, Mufaddal Mamawala, Hiten D Patel, et al.
Urology Case Reports
|
March 9, 2016
Adenocarcinoma of the Ileal Conduit in a Patient Born With Classic Bladder Exstrophy
Joan S Ko, Heather N Di Carlo, Angela D Gupta, et al.
ACS Chemical Neuroscience
|
April 11, 2023
Dynamic and Rapid Detection of Guanosine during Ischemia
Moriah E Weese-Myers, Michael T Cryan, Colby E Witt, et al.
BJU International
|
December 24, 2010
Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity
Ashley E Ross, Ashkan Emadi, Luigi Marchionni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 19, 2013
African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?
Debasish Sundi, Ashley E Ross, Elizabeth B Humphreys, et al.
Page
of 29
Search research articles
Search
Showing results (81-90 of 283) with videos related to
Sort By:
Page
of 29
Nature Reviews. Urology
|
October 12, 2016
Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations
Jeffrey J Tosoian, Michael A Gorin, Ashley E Ross, et al.
Nature Reviews. Urology
|
March 2, 2021
Local anaesthetic techniques for performing transperineal prostate biopsy
Spyridon P Basourakos, Mathew J Allaway, Ashley E Ross, et al.
Journal of Surgical Oncology
|
October 29, 2024
Treatment Modalities and Risks of Complication for Patients With Localized Renal Cell Carcinoma Aged 75 and Older
Chalairat Suk-Ouichai, Hiten D Patel, Kent T Sato, et al.
ACS Sensors
|
February 21, 2024
Waste Coffee Ground-Derived Porous Carbon for Neurochemical Detection
Blaise J Ostertag, Ayah J Syeed, Alexandra K Brooke, et al.
The Oncologist
|
May 11, 2026
The emerging role of prostate-specific membrane antigen-targeted radioligand therapy in metastatic hormone-sensitive prostate cancer
Philipose Mulugeta, Tanya Dorff, Jason Hafron, et al.
The Journal of Urology
|
October 28, 2017
Tumor Volume on Biopsy of Low Risk Prostate Cancer Managed with Active Surveillance
Jeffrey J Tosoian, Mufaddal Mamawala, Hiten D Patel, et al.
Urology Case Reports
|
March 9, 2016
Adenocarcinoma of the Ileal Conduit in a Patient Born With Classic Bladder Exstrophy
Joan S Ko, Heather N Di Carlo, Angela D Gupta, et al.
ACS Chemical Neuroscience
|
April 11, 2023
Dynamic and Rapid Detection of Guanosine during Ischemia
Moriah E Weese-Myers, Michael T Cryan, Colby E Witt, et al.
BJU International
|
December 24, 2010
Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity
Ashley E Ross, Ashkan Emadi, Luigi Marchionni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 19, 2013
African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?
Debasish Sundi, Ashley E Ross, Elizabeth B Humphreys, et al.
Page
of 29